Centiva Capital, LP Karyopharm Therapeutics Inc. Transaction History

Centiva Capital, LP

  • $4.79 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.87 - $1.58 $177,132 - $321,688
203,600 New
203,600 $177,000
Q3 2023

Nov 14, 2023
BUY
$1.14 - $1.81 $14,922 - $23,692
13,090 Added 40.03%
45,790 $61,000
Q2 2023

Aug 14, 2023
BUY
$1.79 - $4.59 $58,533 - $150,093
32,700 New
32,700 $58,000
Q3 2021

Nov 15, 2021
SELL
$4.45 - $10.63 $90,802 - $216,905
-20,405 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$8.11 - $11.11 $165,484 - $226,699
20,405 New
20,405 $211,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email